Laurion Capital Management LP Aclaris Therapeutics, Inc. Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $3.64 Million - $9.25 Million	-515,268 Reduced 42.87%	686,533 $5.55 Million
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $1.47 Million - $1.89 Million	-102,823 Reduced 7.88%	1,201,801 $18.9 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $1.77 Million - $2.47 Million	-135,451 Reduced 9.41%	1,304,624 $20.5 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $3.17 Million - $5.82 Million	325,000 Added 29.15%	1,440,075 $24.8 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $7.64 Million - $11.5 Million	622,575 Added 126.41%	1,115,075 $16.2 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $550,747 - $773,845	-41,162 Reduced 7.71%	492,500 $8.87 Million
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $8.44 Million - $14.6 Million	493,962 Added 1244.24%	533,662 $9.37 Million
Q1 2021 May 14, 2021	BUY	$5.86 - $27.73 $232,642 - $1.1 Million	39,700 New	39,700 $1 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.